Overview
Connectome Health develops AI-enabled neurotechnology aimed at measuring and tracking brain changes in real time. Based in Zurich, the company positions its offering at the intersection of neuroscience, clinical monitoring and research, with an emphasis on delivering continuous, time-resolved neural metrics rather than static snapshots. The company closed a $2M pre-seed on 2026-04-01 led by Redstone and has raised $2M in total. The funding announcement highlights its focus on real-time brain-change tracking; no additional technical specifications, commercial partnerships or customers were disclosed in the round coverage.
Funding History
Redstone leads $2M pre-seed for Zurich neurotech Connectome Health to track brain changes in real time
Frequently Asked Questions
- How much has Connectome Health raised in total?
- Connectome Health has raised a total of $2M across 1 funding round.
- Who are Connectome Health's investors?
- Connectome Health's investors include Undisclosed.
- What does Connectome Health do?
- Connectome Health develops AI-enabled neurotechnology aimed at measuring and tracking brain changes in real time. Based in Zurich, the company positions its offering at the intersection of neuroscience, clinical monitoring and research, with an emphasis on delivering continuous, time-resolved neural metrics rather than static snapshots. The company closed a $2M pre-seed on 2026-04-01 led by Redstone and has raised $2M in total. The funding announcement highlights its focus on real-time brain-change tracking; no additional technical specifications, commercial partnerships or customers were disclosed in the round coverage.
- Where is Connectome Health headquartered?
- Connectome Health is headquartered in Zurich, Switzerland.
Investors
Related Insights
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $35.9 billion raised across 95 deals, with 15 mega-rounds capturing 85.5% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
The AI Healthcare sector is one of the most dynamic areas of AI investment in 2026. This report profiles the top-funded startups in the space, their investors, and the market dynamics driving growth.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.